Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Bohlen
Carsten Bohlen, Cornebarrieu FR
| Patent application number | Description | Published |
|---|---|---|
| 20090218440 | INTEGRATED MULTIFUNCTIONAL POWERED WHEEL SYSTEM FOR AIRCRAFT - The invention relates to a powered wheel system for an aircraft, comprising at least one undercarriage with several rotatably held wheels, with the powered wheel system comprising two or more motors of which in each case at least one motor is coupled to at least one of the wheels, and comprising at least one control device that is coupled to the motors. A control device is equipped to control operation of the motors independently of each other as far as their respective rotary speeds and direction of rotation are concerned, so that the system is able, among other things, to effect taxiing; by means of rotary speed differentials on different motors to be able to steer the aircraft; prior to landing to bring the wheel circumference speeds to landing speed; and to boost the undercarriage brakes of the aircraft. Furthermore, by means of an improvement of the system according to the invention, the rotary speeds of the wheels may be determined with precision. The invention furthermore relates to a method for driving wheels of an aircraft. | 09-03-2009 |
Jean-Marc Bohlen, Cheseaux CH
| Patent application number | Description | Published |
|---|---|---|
| 20080228844 | Method of Enhancing Spectral Data - A method of enhancing spectral data such as a frequency, wavelength or mass spectrum comprises applying an inverse Fourier Transform to the data in the frequency, wavelength or mass spectrum, zero-filling and, optionally, apodizing that inverse transform data, and then applying a Fourier Transform to convert the inverse data back into the frequency, wavelength or mass domain. The resultant processed spectrum provides a more accurate indication of peak location, shape and height. | 09-18-2008 |
John R. Bohlen, Rickman, TN US
| Patent application number | Description | Published |
|---|---|---|
| 20110030560 | AIR CLEANER WITH MULTIPLE ORIENTATIONS - A convertible air cleaner adapted for use in a tower or non-tower orientation including: a housing defining an interior chamber; an air filter disposed in the interior chamber; an air inlet through a first outer face of the housing; and an air outlet through a second face of the housing is described. In the air cleaner, the air inlet is disposed substantially opposite the air outlet, and the air cleaner is adapted to create an airflow between the air inlet and the air outlet when the air cleaner is in a tower or a non-tower orientation. | 02-10-2011 |
John Relman Bohlen, Long Beach, MS US
| Patent application number | Description | Published |
|---|---|---|
| 20100071558 | AIR CLEANER AND SHUT-DOWN METHOD - An air cleaner is provided according to an embodiment of the invention. The air cleaner includes a high voltage power supply configured to provide a high voltage to a collector cell and a shut-down circuit coupled to the high voltage power supply. The shut-down circuit is configured to monitor an electrical current supplied to the collector cell, remove electrical power to the collector cell if the electrical current exceeds a predetermined cell current threshold for a predetermined time period, and generate an indication if the electrical power is removed from the collector cell. | 03-25-2010 |
Johns R. Bohlen, Rickman, TN US
| Patent application number | Description | Published |
|---|---|---|
| 20110033346 | AIR CLEANER WITH PHOTO-CATALYTIC OXIDIZER - An air cleaner comprising an air channel in the air cleaner; an air moving unit configured to create an airflow in the air channel; a photo-catalytic oxidation (PCO) element disposed in the airflow; and a Ultraviolet A (UV-A) Light Emitting Diode (LED) to illuminate the PCO element is described. The PCO element can be a substrate comprising: a first coating comprising a VOC decomposing catalyst; a second coating comprising an ozone decomposing catalyst; and a third coating comprising titanium dioxide. | 02-10-2011 |
Peter Bohlen, New York, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20080311121 | ANTIBODY ANTAGONISTS OF VE-CADHERIN WITHOUT ADVERSE EFFECTS ON VASCULAR PERMEABILITY - The murine epitope sequence recognized by antibody E4B9 shares 100% homology with human VE-cadherin, so this antibody was examined to determine if it cross-reacts with human VE-cadherin. Western-blot analysis of several VE-cadherin expressing human and murine cells indicated that E4B9 indeed cross-reacts with human VE-cadherin. ( | 12-18-2008 |
| 20080317750 | ANTIBODY ANTAGONISTS OF VE-CADHERIN WITHOUT ADVERSE EFFECTS ON VASCULAR PERMEABILITY - The murine epitope sequence recognized by antibody E4B9 shares 100% homology with human VE-cadherin, so this antibody was examined to determine if it cross-reacts with human VE-cadherin. Western-blot analysis of several VE-cadherin expressing human and murine cells indicated that E4B9 indeed cross-reacts with human VE-cadherin (FIG. | 12-25-2008 |
| 20090060909 | ANTIBODY ANTAGONISTS OF VE-CADHERIN WITHOUT ADVERSE EFFECTS ON VASCULAR PERMEABILITY - The murine epitope sequence recognized by antibody E4B9 shares 100% homology with human VE-cadherin, so this antibody was examined to determine if it cross-reacts with human VE-cadherin. Western-blot analysis of several VE-cadherin expressing human and murine cells indicated that E4B9 indeed cross-reacts with human VE-cadherin (FIG. | 03-05-2009 |
| 20100028347 | ANTIBODIES AGAINST VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1 - Monoclonal antibodies that are specific for vascular endothelial growth factor receptor 1 (VEGFR-I). This invention also provides nucleotide sequences encoding and amino acid sequences comprising variable heavy and light chain immunoglobulin molecules, including sequences corresponding to the complementarity determining regions of CDR1, CDR2, and CDR3. The invention also provides methods for generation and expression of anti -VEGFR-I antibodies and methods of treating angiogenic-related disorders and reducing tumor growth by administering anti-VEGFR-I antibodies. | 02-04-2010 |